AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16643492 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (antireflux and direct)
Number of subjects: 60
Study 14657545 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (1200 mg/d for 10 days)
Number of subjects: 28
Study 14657545 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hydrocortisone treatment)
Number of subjects: 28
Study 10816186 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 268
Study 10816186 — intervention group
Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 268
Study 8780337 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 g/d eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA)
Number of subjects: 40
Study 8780337 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.1 g EPA + DHA/d
Number of subjects: 40
Study 8780337 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.7 g EPA + DHA/d
Number of subjects: 40
Study 8780337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1452381 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 6.25 mg
Number of subjects: 19
Study 1452381 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg
Number of subjects: 19
Study 1452381 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 19
Study 1452381 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg
Number of subjects: 19
Study 1452381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 3881175 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose human leukocyte alpha-interferon (10 X 10(6) units/day for 28 days)
Number of subjects: 30
Study 3881175 — intervention group
Group type: COMPARATOR
Intervention: Low dose human leukocyte alpha-interferon (1 X 10(6) units/day for 28 days)
Number of subjects: 30
Study 29894774 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based m-health system for health education and symptom self-management
Number of subjects: 60
Study 29894774 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular treatments only)
Number of subjects: 60
Study 27438995 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene hydrochloride, 120 mg/d
Number of subjects: 56
Study 27438995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 25442691 — intervention group
Group type: EXPERIMENTAL
Intervention: Male circumcision
Number of subjects: 4716
Study 25442691 — intervention group
Group type: EXPERIMENTAL
Intervention: Male circumcision of male partners
Number of subjects: 4716
Study 22281244 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based behavior change management intervention for essential newborn care
Number of subjects: 0
Study 22281244 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 20713879 — intervention group
Group type: EXPERIMENTAL
Intervention: IMC‐A12 monotherapy (10 mg/kg IV every 2 weeks)
Number of subjects: 64
Study 20713879 — intervention group
Group type: EXPERIMENTAL
Intervention: IMC‐A12 plus cetuximab (10 mg/kg IMC-A12 and 500 mg/m2 cetuximab IV every 2 weeks)
Number of subjects: 64
Study 20713879 — intervention group
Group type: EXPERIMENTAL
Intervention: IMC‐A12 plus cetuximab (arm C, same as arm B)
Number of subjects: 64
Study 20713879 — intervention group
Group type: EXPERIMENTAL
Intervention: IMC‐A12 (serious adverse events)
Number of subjects: 64
Study 18413068 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate 150 mg/day (days 3 to 7) + oral phytoestrogen (Cimicifuga racemosa) 120 mg/day (days 1 to 12)
Number of subjects: 119
Study 18413068 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate 150 mg/day (days 3 to 7)
Number of subjects: 119
Study 16190795 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release methylphenidate (ER-MPH) 40 mg
Number of subjects: 53
Study 16190795 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release methylphenidate (ER-MPH) 20 mg
Number of subjects: 53
Study 16190795 — intervention group
Group type: COMPARATOR
Intervention: OROS-methylphenidate (OROS-MPH) 36 mg
Number of subjects: 53
Study 16190795 — intervention group
Group type: COMPARATOR
Intervention: OROS-methylphenidate (OROS-MPH) 18 mg
Number of subjects: 53
Study 12481675 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (10 g and 20 g) with saline cathartics (Na2SO4 and MgSO4)
Number of subjects: 5
Study 12481675 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (10 g) with magnesium sulphate and propantheline (15 mg)
Number of subjects: 5
Study 12481675 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (10 g) with metoclopramide (10 mg)
Number of subjects: 5
Study 12481675 — intervention group
Group type: COMPARATOR
Intervention: Placebo liquid
Number of subjects: 5
Study 12481675 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 5
Study 9932569 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg misoprostol administered orally
Number of subjects: 30
Study 9932569 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg misoprostol administered vaginally
Number of subjects: 30
Study 7768257 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF1194 tablet (20 mg piroxicam)
Number of subjects: 12
Study 2181701 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron 2 mg/kg/d until the age of 6 months
Number of subjects: 2
Study 2181701 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular iron dextran 100 mg between the ages of 6 and 8 weeks
Number of subjects: 2
Study 111279 — intervention group
Group type: EXPERIMENTAL
Intervention: LAAM (1-Alpha-acetylmethadol) administered every other day
Number of subjects: 17
Study 111279 — intervention group
Group type: COMPARATOR
Intervention: Methadone administered every day
Number of subjects: 17
Study 30702405 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal Adhesive
Number of subjects: 34
Study 30702405 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2
Number of subjects: 34
Study 30702405 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 34
Study 30702405 — intervention group
Group type: COMPARATOR
Intervention: Conventional etch-and-rinse
Number of subjects: 34
Study 30702405 — intervention group
Group type: COMPARATOR
Intervention: Self-etching systems
Number of subjects: 34
Study 29905384 — intervention group
Group type: EXPERIMENTAL
Intervention: CLNP/BPO 3%
Number of subjects: 351
Study 29905384 — intervention group
Group type: COMPARATOR
Intervention: ADA + CLNP
Number of subjects: 351
Study 26634889 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimarker model combining blood urea nitrogen (BUN), chloride, interleukin (IL)-6, cTnI, sST-2, and VEGFR-1
Number of subjects: 2033
Study 26634889 — intervention group
Group type: EXPERIMENTAL
Intervention: Late biomarker measurements
Number of subjects: 2033
Study 26634889 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline levels of biomarkers
Number of subjects: 2033
Study 26634889 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimarker models
Number of subjects: 2033
Study 26634889 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent measurements of biomarkers
Number of subjects: 2033
Study 25180869 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose terlipressin (1 mg/6-8 h, n=27)
Number of subjects: 56
Study 25180869 — intervention group
Group type: COMPARATOR
Intervention: Low-dose terlipressin (1 mg/12 h, n=29)
Number of subjects: 56
Study 21982700 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote telemedical management (RTM)
Number of subjects: 710
Study 21982700 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 710
Study 19862519 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-DOPA PET/CT
Number of subjects: 25
Study 19862519 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 25
Study 19862519 — intervention group
Group type: COMPARATOR
Intervention: (18)F-DOPA PET
Number of subjects: 25
Study 17658663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream
Number of subjects: 40
Study 17658663 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1% paste
Number of subjects: 40
Study 16210047 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.1 mg/kg weight)
Number of subjects: 10
Study 16210047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12765673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional support
Number of subjects: 128
Study 12765673 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition
Number of subjects: 128
Study 12765673 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral or oral nutrition
Number of subjects: 128
Study 10695777 — intervention group
Group type: EXPERIMENTAL
Intervention: artemisinin (total dose of 60 mg/kg)
Number of subjects: 126
Study 10695777 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate (total dose of 12 mg/kg over five days)
Number of subjects: 126
Study 10695777 — intervention group
Group type: COMPARATOR
Intervention: artemisinin (effectiveness group)
Number of subjects: 126
Study 10695777 — intervention group
Group type: COMPARATOR
Intervention: artesunate (effectiveness group)
Number of subjects: 126
Study 8568294 — intervention group
Group type: EXPERIMENTAL
Intervention: Envelope subunit vaccine products
Number of subjects: 50
Study 8568294 — intervention group
Group type: COMPARATOR
Intervention: Serum from HIV-1-infected persons
Number of subjects: 50
Study 1764826 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective visual echocardiographic estimate of LVEF
Number of subjects: 40
Study 1764826 — intervention group
Group type: EXPERIMENTAL
Intervention: Cubed M-mode formula
Number of subjects: 40
Study 1764826 — intervention group
Group type: EXPERIMENTAL
Intervention: Teichholz M-mode formula
Number of subjects: 40
Study 1764826 — intervention group
Group type: EXPERIMENTAL
Intervention: Length-area method from the four-chamber view
Number of subjects: 40
Study 1764826 — intervention group
Group type: EXPERIMENTAL
Intervention: Simpson's single plane formula
Number of subjects: 40
Study 6887360 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfisoxazole 2 gm initially and 1 gm 4 times daily for 3 days (group 1)
Number of subjects: 146
Study 6887360 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfisoxazole 2 gm initially and 1 gm 4 times daily for 7 days (group 2)
Number of subjects: 146
Study 6887360 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfisoxazole 2 gm initially and 1 gm 4 times daily for 14 days (group 3)
Number of subjects: 146
Study 6887360 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfisoxazole 2 gm initially and 1 gm 4 times daily for 21 days (group 4)
Number of subjects: 146
Study 6887360 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfisoxazole (3-day course)
Number of subjects: 146
Study 31294505 — intervention group
Group type: EXPERIMENTAL
Intervention: Success-based orientation
Number of subjects: 394
Study 31294505 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous success-based and failure-based orientation
Number of subjects: 394
Study 31294505 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure-based orientation
Number of subjects: 394
Study 27436502 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultracongruent (UC) tibial inserts
Number of subjects: 105
Study 27436502 — intervention group
Group type: COMPARATOR
Intervention: Cruciate retaining (CR) tibial inserts
Number of subjects: 105
Study 26383722 — intervention group
Group type: EXPERIMENTAL
Intervention: Visually Guided Laser Balloon (VGLB)
Number of subjects: 353
Study 26383722 — intervention group
Group type: COMPARATOR
Intervention: Standard irrigated radiofrequency ablation (RFA)
Number of subjects: 353
Study 24144440 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER (various weight-based doses)
Number of subjects: 201
Study 24144440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 21335032 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 Lot 1
Number of subjects: 0
Study 21335032 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 Lot 2
Number of subjects: 0
Study 19813462 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (alendronate 70 mg tablets)
Number of subjects: 80
Study 19813462 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (alendronate 70 mg)
Number of subjects: 80
Study 18164920 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg QD
Number of subjects: 0
Study 18164920 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg BID
Number of subjects: 0
Study 18164920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15180739 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 1009
Study 15180739 — intervention group
Group type: EXPERIMENTAL
Intervention: CT colonography
Number of subjects: 1009
Study 15180739 — intervention group
Group type: COMPARATOR
Intervention: Choice of tests (Colonoscopy or CT colonography)
Number of subjects: 1009
Study 11147625 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest X-ray screening
Number of subjects: 0
Study 8862262 — intervention group
Group type: COMPARATOR
Intervention: Steroid therapy
Number of subjects: 39
Study 8862262 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial epicondylectomy and external decompression
Number of subjects: 39
Study 1725151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime 8 mg/kg once daily at bedtime for 10 days
Number of subjects: 40
Study 1725151 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin 50 mg/kg/day in 3 divided doses for 10 days
Number of subjects: 40
Study 1725151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime and Amoxicillin
Number of subjects: 40
Study 6724511 — intervention group
Group type: COMPARATOR
Intervention: Child-Turcotte criteria (CTC) score
Number of subjects: 245
Study 31580003 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal (TV) route
Number of subjects: 58
Study 31580003 — intervention group
Group type: COMPARATOR
Intervention: Transabdominal (TA) route
Number of subjects: 58
Study 30083110 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinemotion training (delivered in weekly group sessions)
Number of subjects: 31
Study 30083110 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinemotion training
Number of subjects: 31
Study 30083110 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 31
Study 29282952 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle knife therapy combined with rotation traction manipulation
Number of subjects: 80
Study 29282952 — intervention group
Group type: COMPARATOR
Intervention: Rotation traction manipulation (Control)
Number of subjects: 80
Study 22432484 — intervention group
Group type: EXPERIMENTAL
Intervention: LI4 acupressure
Number of subjects: 100
Study 22432484 — intervention group
Group type: COMPARATOR
Intervention: Touch without massage (Control)
Number of subjects: 100
Study 20473733 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine comprehensive therapy (Oleum fructus bruceas, Ganji Decoction, Ailitong)
Number of subjects: 97
Study 20473733 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine comprehensive therapy
Number of subjects: 97
Study 20473733 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapeutic agents with iodized oil chemo-embolization and analgesics
Number of subjects: 97
Study 18355648 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright stance
Number of subjects: 0
Study 18355648 — intervention group
Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 0
Study 16202258 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Leflunomide (LEF)
Number of subjects: 51
Study 16202258 — intervention group
Group type: COMPARATOR
Intervention: IV Cyclophosphamide
Number of subjects: 51
Study 16202258 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide (LEF) in relapsed patients
Number of subjects: 51
Study 12211512 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher frequency (5-7 days per week)
Number of subjects: 379
Study 12211512 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity (45%-55% of maximum heart rate reserve)
Number of subjects: 379
Study 12211512 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity (65%-75% of maximum heart rate reserve)
Number of subjects: 379
Study 10230146 — intervention group
Group type: EXPERIMENTAL
Intervention: System of care
Number of subjects: 350
Study 10230146 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 350
Study 10230146 — intervention group
Group type: EXPERIMENTAL
Intervention: No services
Number of subjects: 350
Study 8966308 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamidine 4 mg/kg/every 2 days for 8 applications
Number of subjects: 46
Study 8966308 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminosidine 20 mg/kg/day for 20 days
Number of subjects: 46
Study 8966308 — intervention group
Group type: EXPERIMENTAL
Intervention: Meglumine 10 mg Sbv/kg/day for 20 days
Number of subjects: 46
Study 8966308 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up after 3 years
Number of subjects: 46
Study 1898891 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose follicle-stimulating hormone (FSH)
Number of subjects: 30
Study 1898891 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose human menopausal gonadotropin (hMG)
Number of subjects: 30
Study 6331270 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (40 mg X 3 daily and 80 mg at bedtime)
Number of subjects: 50
Study 6331270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 31112494 — intervention group
Group type: EXPERIMENTAL
Intervention: Onetime home nurse visit
Number of subjects: 0
Study 31112494 — intervention group
Group type: COMPARATOR
Intervention: Parent recall of reutilization events
Number of subjects: 0
Study 29558967 — intervention group
Group type: EXPERIMENTAL
Intervention: Juanbi pill
Number of subjects: 120
Study 26423446 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss achieved with reduced energy intake and increased physical activity (PA) for 0-6 months; maintenance provided adequate energy to maintain weight and continued PA for 7-18 months
Number of subjects: 359
Study 26423446 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy for weight management and exercise barriers
Number of subjects: 359
Study 24768543 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Tranexamic Acid (2.0g)
Number of subjects: 89
Study 24768543 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Tranexamic Acid (10mg/kg)
Number of subjects: 89
Study 24768543 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Tranexamic Acid
Number of subjects: 89
Study 23159258 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 kcal/kg per week aerobic training
Number of subjects: 325
Study 23159258 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 kcal/kg per week aerobic training
Number of subjects: 325
Study 23159258 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 kcal/kg per week aerobic training
Number of subjects: 325
Study 23159258 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 325
Study 20051288 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose 200 mg
Number of subjects: 44
Study 20051288 — intervention group
Group type: COMPARATOR
Intervention: Oral ferrous sulphate 600 mg/day
Number of subjects: 44
Study 18081185 — intervention group
Group type: EXPERIMENTAL
Intervention: SOMA Safe Enclosure
Number of subjects: 49
Study 18081185 — intervention group
Group type: COMPARATOR
Intervention: Standard Restraints
Number of subjects: 49
Study 17265577 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified version of the HIV vaccine process
Number of subjects: 187
Study 17265577 — intervention group
Group type: COMPARATOR
Intervention: Standard version of the HIV vaccine process
Number of subjects: 187
Study 17265577 — intervention group
Group type: EXPERIMENTAL
Intervention: Both versions (simplified and standard)
Number of subjects: 187
Study 14973564 — intervention group
Group type: EXPERIMENTAL
Intervention: Miswak (chewing stick)
Number of subjects: 40
Study 14973564 — intervention group
Group type: COMPARATOR
Intervention: Toothbrush
Number of subjects: 40
Study 14973564 — intervention group
Group type: EXPERIMENTAL
Intervention: Miswak extract (50% solution)
Number of subjects: 40
Study 14973564 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 40
Study 14973564 — intervention group
Group type: EXPERIMENTAL
Intervention: Miswak
Number of subjects: 40
Study 10637236 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI 5‐FU/LV
Number of subjects: 168
Study 10637236 — intervention group
Group type: COMPARATOR
Intervention: IV 5‐FU/LV
Number of subjects: 168
Study 10637236 — intervention group
Group type: COMPARATOR
Intervention: HAI FUDR
Number of subjects: 168
Study 9156505 — intervention group
Group type: EXPERIMENTAL
Intervention: Myrtol standardized
Number of subjects: 331
Study 9156505 — intervention group
Group type: EXPERIMENTAL
Intervention: Other essential oil
Number of subjects: 331
Study 9156505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study 8471679 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaprotiline (a highly specific inhibitor of NA uptake)
Number of subjects: 0
Study 8471679 — intervention group
Group type: COMPARATOR
Intervention: Levoprotiline (devoid of NA uptake property)
Number of subjects: 0
Study 3896016 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 200 mg
Number of subjects: 57
Study 3896016 — intervention group
Group type: COMPARATOR
Intervention: Cosalgesic (dextropropoxyphene hydrochloride 65 mg and paracetamol 650 mg)
Number of subjects: 57
Study 11277684 — intervention group
Group type: EXPERIMENTAL
Intervention: Current SLT use
Number of subjects: 7865
Study 11277684 — intervention group
Group type: EXPERIMENTAL
Intervention: Past SLT use
Number of subjects: 7865
Study 31351445 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation with volume guaranteed mode (PCV-VG)
Number of subjects: 36
Study 31351445 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled ventilation mode (VCV)
Number of subjects: 36